Athelas, Incorporated

Athelas, Incorporated is a technology company specializing in healthcare automation and artificial intelligence solutions. Their products streamline administrative tasks and enhance clinical documentation to improve efficiency in medical practices. Founded in 2016 in Mountain View, US, Athelas, Incorporated develops innovative software aimed at enhancing healthcare practices. The company has conducted various funding rounds, with the latest being a Series B round raising USD 54.

39 mn on October 4, 2023. Athelas was co-founded by Deepika Bodapati and Tanay Tandon, who is also the CEO. The company has successfully raised a total of USD 54. 39 mn to date, achieving a current valuation of USD 1,371.

27 mn. Athelas offers an integrated suite of products designed to enhance healthcare practices through automation and artificial intelligence (AI). The core offerings include Ambient AI, an advanced documentation tool that assists clinicians in drafting clinical notes in real-time, streamlining workflows by automatically generating CPT and ICD-10 codes. Additionally, the platform features AI-powered Revenue Cycle Management (RCM) tools that accelerate claim processing, reduce denial rates, and optimize financial performance by analyzing millions of data points for actionable insights.

Athelas serves a diverse client base that includes medical practices, billing companies, and healthcare organizations across North America, Europe, and Asia. These products cater to various end-users, from medical practitioners to administrative staff, enabling them to focus more on patient care and significantly reduce administrative burdens. The revenue structure of Athelas is primarily built around subscription-based models for its software services, which include RCM, the Ambient AI scribe, and AI Agents designed to automate various administrative tasks. Clients engage with Athelas through contracts that may vary in length and complexity, reflecting the tailored nature of the services provided.

Transactions are executed on a B2B basis, where healthcare practices pay for the services based on their specific needs and the number of providers utilizing the system. Although specific pricing plans are not disclosed, the comprehensive nature of their flagship products suggests that clients may incur costs based on usage levels, feature access, and the scale of their operations. Athelas's innovative solutions aim to optimize the revenue cycle for healthcare providers, ultimately improving their financial outcomes and operational efficiency. In October 2023, Athelas, Incorporated agreed to merge into Commure, Inc.

, a move expected to bolster its growth opportunities and enhance its AI-enabled workflow platform to drive further operational efficiency for health systems. The merger, supported by investors including General Catalyst Partners and Sequoia Capital, will provide Athelas with resources to expand its product offerings and enter new markets. Specific plans for launching upcoming products have not been detailed, but the merger is anticipated to enable the company to strengthen its position in existing and potentially new geographic regions.